MDxHealth (MDXH) Cash & Equivalents Growth (3y) (2023 - 2026)

MDxHealth (MDXH) Cash & Equivalents Growth (3y) (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash & Equiv. Growth (3y) (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	9.06%
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	-20.26%
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	42.38%
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	15.43%
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	11.37%
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	14.02%
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	-12.51%
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	-14.97%
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	-58.12%
10	MDxHealth	36.03 Mn	15.62 Mn	17.89 Mn	-21.35%

Download Data